Nothnick Warren B, Falcone Tommaso, Olson Mark R, Fazleabas Asgerally T, Tawfik Ossama W, Graham Amanda
1 Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.
2 Center for Reproductive Sciences, University of Kansas Medical Center, Kansas City, KS, USA.
Reprod Sci. 2018 Nov;25(11):1557-1566. doi: 10.1177/1933719118766262. Epub 2018 Mar 28.
CD74 is the primary receptor for macrophage migration inhibitory factor (MIF). Although expression of MIF has been described in endometriotic lesions, the cellular localization and function of the MIF receptor, CD74, are poorly understood. To further explore the role of CD74 in the pathophysiology of endometriosis, we utilized specimens from women with diagnostically confirmed endometriosis, women with no signs or symptoms of endometriosis (controls), and 8 baboons with experimentally induced endometriosis. Compared to eutopic endometrium from women with endometriosis, CD74 transcript expression was significantly increased in endometriotic lesion tissue. Similarly, cellular expression of CD74 was significantly greater in ectopic lesion tissue compared to paired eutopic endometrium, which both expressed greater CD74 expression compared to eutopic endometrium from control patients. Localization of CD74 was predominant to epithelial cells of ectopic and matched eutopic endometrium and was not influenced by the stage of the menstrual cycle. Eutopic endometrium from control patients did not express detectable levels of CD74 protein by immunohistochemistry. This pattern of expression and CD74 protein localization could be recapitulated in endometriotic lesion tissue from baboons with experimentally induced disease. Transfection of the endometriotic epithelial cell lines, 12Z with CD74 short hairpin RNA (shRNA), resulted in a significant decrease in CD74 protein expression, which was associated with a significant reduction in cellular proliferation as well as the expression of the prosurvival cytokine interleukin 8. Together, these data support the hypothesis that CD74 is elevated in endometriotic lesion tissue and may contribute to the pathogenesis of endometriosis by promoting cell survival.
CD74是巨噬细胞移动抑制因子(MIF)的主要受体。虽然MIF在子宫内膜异位症病灶中的表达已有报道,但对MIF受体CD74的细胞定位和功能却知之甚少。为了进一步探究CD74在子宫内膜异位症病理生理学中的作用,我们使用了经诊断确诊为子宫内膜异位症的女性、无子宫内膜异位症体征或症状的女性(对照组)以及8只实验性诱导子宫内膜异位症的狒狒的标本。与子宫内膜异位症女性的在位内膜相比,CD74转录本表达在异位病灶组织中显著增加。同样,与配对的在位内膜相比,异位病灶组织中CD74的细胞表达也显著更高,而这两者的CD74表达均高于对照组患者的在位内膜。CD74主要定位于异位和配对在位内膜的上皮细胞,且不受月经周期阶段的影响。通过免疫组织化学,对照组患者的在位内膜未检测到可检测水平的CD74蛋白。这种表达模式和CD74蛋白定位在实验性诱导疾病的狒狒的子宫内膜异位症病灶组织中也可重现。用CD74短发夹RNA(shRNA)转染子宫内膜异位上皮细胞系12Z,导致CD74蛋白表达显著降低,这与细胞增殖以及促生存细胞因子白细胞介素8的表达显著减少有关。总之,这些数据支持以下假设:CD74在子宫内膜异位症病灶组织中升高,可能通过促进细胞存活而有助于子宫内膜异位症的发病机制。